Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours Β· Estimated delivery Aug 3 - Aug 8
Retatrutide assists with liver fat and metabolic health, which are significant issues for individuals with obesity or metabolic syndrome
A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome
Direct-to-consumer subscriptions for powder-based supplements rose 18.2% in 2025
However, our prior work has shown that many patients stop taking GLP-1 RAs prematurely
Workers with obesity have roughly 76% higher short-term disability rates than their normal-weight colleagues, meaning every employee who gains stable access to effective obesity treatment is statistically far less likely to go out on disability leave
Medication costs starting at $349 a month (before any manufacturer promotional pricing) Foundayo (Oral) Foundayo (orforglipron) pill, a FDA-approved GLP-1 receptor agonist, taken once a day, to help regulate appetite and feelings of fullness
US$ 25.16
US$ 27.90
US$ 22.91
US$ 27.20
US$ 24.39
US$ 23.04
US$ 29.16
